We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

200 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 66 increasing their positions, 57 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 26

21% more call options, than puts

Call options by funds: $12.5M | Put options by funds: $10.4M

16% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 57

8.95% more ownership

Funds ownership: 106.46% → 115.41% (+9%)

2% more funds holding

Funds holding: 197 → 200 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less capital invested

Capital invested by funds: $1.16B → $1.07B (-$87.7M)

Holders
200
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
66
Reduced
57
Closed
26
Calls
$12.5M
Puts
$10.4M
Net Calls
+$2.14M
Net Calls Change
+$80K

Top Buyers

1
UOC
UBS O'Connor
Illinois
+$16.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$15.8M
3
State Street
State Street
Massachusetts
+$12.3M
4
Millennium Management
Millennium Management
New York
+$10.3M
5
SCM
Suvretta Capital Management
New York
+$10.2M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$17.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.01M
3
GLA
Great Lakes Advisors
Illinois
-$7.94M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.24M
5
PAM
Panagora Asset Management
Massachusetts
-$4.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
151
Ameritas Investment Partners
Nebraska
$65K – – –
JEST
152
JTC Employer Solutions Trustee
Jersey
$59K – – –
EL
153
EMFO LLC
Florida
$55K – – –
Canada Life
154
Canada Life
Manitoba, Canada
$42K – – –
Russell Investments Group
155
Russell Investments Group
United Kingdom
$39K +$43.9K +4,302 New
FF
156
FourThought Financial
Florida
$32K – – –
ZIG
157
Zullo Investment Group
Pennsylvania
$30K +$33.7K +3,300 New
BCV
158
Banque Cantonale Vaudoise
Switzerland
$27K – – –
EC
159
Estate Counselors
Wisconsin
$27K – – –
Fifth Third Bancorp
160
Fifth Third Bancorp
Ohio
$27K – – –
CG
161
Cutler Group
California
$26K – – –
MIFH
162
Migdal Insurance & Financial Holdings
Israel
$21K -$12.3K -1,209 -35%
PNC Financial Services Group
163
PNC Financial Services Group
Pennsylvania
$16K – – –
CA
164
Clearstead Advisors
Ohio
$13K – – –
CFGS
165
Concourse Financial Group Securities
Alabama
$12K +$2.64K +259 +24%
Nisa Investment Advisors
166
Nisa Investment Advisors
Missouri
$9K -$88.9K -8,704 -89%
Northwestern Mutual Wealth Management
167
Northwestern Mutual Wealth Management
Wisconsin
$9K -$26.5K -2,600 -72%
SPIA
168
Steward Partners Investment Advisory
New York
$9K – – –
WAS
169
Winch Advisory Services
Wisconsin
$9K – – –
LWP
170
Lumature Wealth Partners
Georgia
$8K – – –
KT
171
Kevin Tang
$7K – – –
CAPTRUST Financial Advisors
172
CAPTRUST Financial Advisors
North Carolina
$5K -$3.78K -370 -42%
National Bank of Canada
173
National Bank of Canada
Quebec, Canada
$5K +$6.13K +600 New
SOW
174
State of Wyoming
Wyoming
$4K -$235 -23 -5%
EWM
175
Endurance Wealth Management
Rhode Island
$4K – – –
5 6
7
8 9

HRTX Hedge Fund Activity: Q4 2021 in Review

200 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q4 2021, worth a combined $1.07B — down 7.6% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new HRTX positions and 26 closed out — a net gain of 6 holders — while 66 added to existing stakes and 57 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $16.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.1M sold.

  • 200 institutional investors held Heron Therapeutics (HRTX) as of Q4 2021, up from 197 in Q3 2021.
  • Funds reported $1.07B of Heron Therapeutics stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 32 funds opened new Heron Therapeutics positions in Q4 2021 and 26 closed out, a net change of +6 holders.
  • The largest Heron Therapeutics buyer in Q4 2021 was UBS O'Connor, an estimated $16.8M added.
  • The largest Heron Therapeutics seller in Q4 2021 was Point72 Asset Management, an estimated $17.1M sold.

Based on aggregated 13F filings for Q4 2021.